Assignee
INFLECTIS BIOSCIENCE
FR·4 granted patents·2 pending applications·0 citations·filing 2015–2023
Top patents by PatentIndex Score
6 records- 0153US11084783B2O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteinsINFLECTIS BIOSCIENCE·Filed 2019·Granted Aug 10, 2021·0 cites·11 claims
- 0253US2020289436A1Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathiesINFLECTIS BIOSCIENCE·Filed 2020·Application pending·0 cites
- 0349US2024293343A1Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applicationsINFLECTIS BIOSCIENCE·Filed 2023·Application pending·0 cites
- 0446US10709677B2Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathiesINFLECTIS BIOSCIENCE·Filed 2015·Granted Jul 14, 2020·0 cites·12 claims
- 0541US10544093B2O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteinsINFLECTIS BIOSCIENCE·Filed 2015·Granted Jan 28, 2020·0 cites·17 claims
- 0627US10675257B2Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agentINFLECTIS BIOSCIENCE·Filed 2016·Granted Jun 9, 2020·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when INFLECTIS BIOSCIENCE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →